|Buyback Dates||01/01/2020 - 14/01/2020|
|Buyback Offer||Rs.100.00 crores|
|Buyback Offer Size||1.26%|
|Number of Shares||17,39,000|
|Buyback Type||Tender Offer|
Incorporated in 2007, Eris Lifesciences Limited is a full integrated Pharmaceutical company. The company is a leading manufacturer of chronic category and acute category. The company is second fastest growing in Chronic therapy segment. Company is focused on formulations market of cardiovascular; anti-diabetes; vitamins; gastroenterology and gynecology.
July 4th, 2019:Eris Lifesciences Limited (BSE:540596 | NSE:ERIS) board has approved a proposal for purchase of up to 17.39 lakh(Seventeen lakhs and thirty nine thousand) shares at Rs 575 (Five hundred seventy five) per share, aggregating Rs 100 Cr(one hundred crore) (Buyback Offer Size) that is 1.26% of total paid- up equity capital of the Company.
CASH OFFER FORBUYBACK OF UPTO 1,739,130FULLY PAID-UP EQUITY SHARES OF FACE VALUE OF RE.1/-EACH, REPRESENTING APPROXIMATELY 1.26% OF THE TOTAL NUMBER OF EQUITY SHARES IN THE ISSUED, SUBSCRIBED AND PAID-UP EQUITY SHARE CAPITAL OF THE COMPANY, FROM THE EXISTING SHAREHOLDERS / BENEFICIAL OWNERS OF EQUITY SHARES OF THE COMPANY AS ON THE RECORD DATE I.E. JULY 15, 2019, ON A PROPORTIONATE BASIS, THROUGH THE “TENDER OFFER” ROUTE AT A PRICE OF RS. 575/-(RUPEES FIVEHUNDRED SEVENTY FIVE ONLY) PER EQUITY SHARE FOR AN AGGREGATE AMOUNT NOT EXCEEDING RS. 1,000 MILLION (RUPEES ONETHOUSAND MILLIONONLY)
The Record Date for Eris Lifesciences Limited Buyback is 15/07/2019.
The Eris Lifesciences Limited Buyback will open on 01/01/2020 and closes on 14/01/2020.
The Buyback price of Eris Lifesciences Limited is Rs.575.
The Buyback Type of Eris Lifesciences Limited is Tender Offer.